chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray normal, Dyspnoea, Electrocardiogram normal, Fatigue, Heart rate increased
Clinical narrative: her heart rate would be 135/ racing heart; racing heart that lasted 2 months; really bad shortness of breath; This is a spontaneous report from a contactable consumer reporting for herself.   A 38-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 18Mar2021 at 13:30 (Batch/Lot number was not reported) as a single dose (at the age of 38 years old) for COVID-19 immunization.  There was no medical history or concomitant medications. There was no relevant family medical history. There was no additional vaccines administered on the same date as the Pfizer vaccine and no prior vaccines administered within 4 weeks. There were no adverse events following prior vaccinations. The patient reported she received the Pfizer Covid-19/Comirnaty vaccine on 18Mar2021. 7 days later (on 25Mar2021) she developed "really bad shortness of breath" and a racing heart that lasted 2 months. The onset time of the events was morning, around 10:00-11:00a.m. Patient reported they were on the way to (City), and it started happening. Sometimes she would wake up and her heart rate would be 135, and she was sleeping and she would get shortness of breath, "it was really scary." Tests showed that everything was fine. They did an echocardiogram with "bubbles," Chest CT with dye, bloodwork, chest x-rays, and they were all normal. She also wore a heart monitor for 2 days. During the time when her heart rate was really bad, she was on a beta blocker for a couple of months to slow her heart rate, but she was able to stop taking that. Treatment included PROZAC, which reporter stated was the only way she could keep it under control. She states she feels much better, but she would still say that it was ongoing but improved because she was still on the PROZAC for it. The events required a visit to the emergency room and physician's office. She did not get the second dose of the vaccine because of this adverse event. The patient was recovering from the events. She wanted to know if she were to go proceed with the second dose now, would she need to re-start the series or only take one dose.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Laboratory test normal, Malaise, Sleep disorder
Clinical narrative: her heart rate would be 135/ racing heart; racing heart that lasted 2 months; really bad shortness of breath; This is a spontaneous report from a contactable consumer reporting for herself.   A 38-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 18Mar2021 at 13:30 (Batch/Lot number was not reported) as a single dose (at the age of 38 years old) for COVID-19 immunization.  There was no medical history or concomitant medications. There was no relevant family medical history. There was no additional vaccines administered on the same date as the Pfizer vaccine and no prior vaccines administered within 4 weeks. There were no adverse events following prior vaccinations. The patient reported she received the Pfizer Covid-19/Comirnaty vaccine on 18Mar2021. 7 days later (on 25Mar2021) she developed "really bad shortness of breath" and a racing heart that lasted 2 months. The onset time of the events was morning, around 10:00-11:00a.m. Patient reported they were on the way to (City), and it started happening. Sometimes she would wake up and her heart rate would be 135, and she was sleeping and she would get shortness of breath, "it was really scary." Tests showed that everything was fine. They did an echocardiogram with "bubbles," Chest CT with dye, bloodwork, chest x-rays, and they were all normal. She also wore a heart monitor for 2 days. During the time when her heart rate was really bad, she was on a beta blocker for a couple of months to slow her heart rate, but she was able to stop taking that. Treatment included PROZAC, which reporter stated was the only way she could keep it under control. She states she feels much better, but she would still say that it was ongoing but improved because she was still on the PROZAC for it. The events required a visit to the emergency room and physician's office. She did not get the second dose of the vaccine because of this adverse event. The patient was recovering from the events. She wanted to know if she were to go proceed with the second dose now, would she need to re-start the series or only take one dose.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chest X-ray, Computerised tomogram thorax, Dyspnoea, Echocardiogram
Clinical narrative: her heart rate would be 135/ racing heart; racing heart that lasted 2 months; really bad shortness of breath; This is a spontaneous report from a contactable consumer reporting for herself.   A 38-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 18Mar2021 at 13:30 (Batch/Lot number was not reported) as a single dose (at the age of 38 years old) for COVID-19 immunization.  There was no medical history or concomitant medications. There was no relevant family medical history. There was no additional vaccines administered on the same date as the Pfizer vaccine and no prior vaccines administered within 4 weeks. There were no adverse events following prior vaccinations. The patient reported she received the Pfizer Covid-19/Comirnaty vaccine on 18Mar2021. 7 days later (on 25Mar2021) she developed "really bad shortness of breath" and a racing heart that lasted 2 months. The onset time of the events was morning, around 10:00-11:00a.m. Patient reported they were on the way to (City), and it started happening. Sometimes she would wake up and her heart rate would be 135, and she was sleeping and she would get shortness of breath, "it was really scary." Tests showed that everything was fine. They did an echocardiogram with "bubbles," Chest CT with dye, bloodwork, chest x-rays, and they were all normal. She also wore a heart monitor for 2 days. During the time when her heart rate was really bad, she was on a beta blocker for a couple of months to slow her heart rate, but she was able to stop taking that. Treatment included PROZAC, which reporter stated was the only way she could keep it under control. She states she feels much better, but she would still say that it was ongoing but improved because she was still on the PROZAC for it. The events required a visit to the emergency room and physician's office. She did not get the second dose of the vaccine because of this adverse event. The patient was recovering from the events. She wanted to know if she were to go proceed with the second dose now, would she need to re-start the series or only take one dose.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram ambulatory, Heart rate, Palpitations, Tachycardia
Clinical narrative: her heart rate would be 135/ racing heart; racing heart that lasted 2 months; really bad shortness of breath; This is a spontaneous report from a contactable consumer reporting for herself.   A 38-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 18Mar2021 at 13:30 (Batch/Lot number was not reported) as a single dose (at the age of 38 years old) for COVID-19 immunization.  There was no medical history or concomitant medications. There was no relevant family medical history. There was no additional vaccines administered on the same date as the Pfizer vaccine and no prior vaccines administered within 4 weeks. There were no adverse events following prior vaccinations. The patient reported she received the Pfizer Covid-19/Comirnaty vaccine on 18Mar2021. 7 days later (on 25Mar2021) she developed "really bad shortness of breath" and a racing heart that lasted 2 months. The onset time of the events was morning, around 10:00-11:00a.m. Patient reported they were on the way to (City), and it started happening. Sometimes she would wake up and her heart rate would be 135, and she was sleeping and she would get shortness of breath, "it was really scary." Tests showed that everything was fine. They did an echocardiogram with "bubbles," Chest CT with dye, bloodwork, chest x-rays, and they were all normal. She also wore a heart monitor for 2 days. During the time when her heart rate was really bad, she was on a beta blocker for a couple of months to slow her heart rate, but she was able to stop taking that. Treatment included PROZAC, which reporter stated was the only way she could keep it under control. She states she feels much better, but she would still say that it was ongoing but improved because she was still on the PROZAC for it. The events required a visit to the emergency room and physician's office. She did not get the second dose of the vaccine because of this adverse event. The patient was recovering from the events. She wanted to know if she were to go proceed with the second dose now, would she need to re-start the series or only take one dose.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Peripheral swelling
Clinical narrative: swollen lymph node that is red; left arm was hurting; had a lot of pain where I got the injection; This is a spontaneous report from a contactable consumer (patient herself). A 65-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 14Feb2021 (Sunday) (age at vaccination: 65 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were none. On an unknown date, the patient experienced swollen lymph node that is red. On 15Feb2021, the patient had a lot of pain where she got the injection. On 16Feb2021, the patient's left arm was hurting and had a swollen lymph node under her arm and it is red and tender to touch and it hurts. The patient did not receive any treatment for the adverse events. The outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Pain in extremity, Vaccination site pain
Clinical narrative: swollen lymph node that is red; left arm was hurting; had a lot of pain where I got the injection; This is a spontaneous report from a contactable consumer (patient herself). A 65-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 14Feb2021 (Sunday) (age at vaccination: 65 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were none. On an unknown date, the patient experienced swollen lymph node that is red. On 15Feb2021, the patient had a lot of pain where she got the injection. On 16Feb2021, the patient's left arm was hurting and had a swollen lymph node under her arm and it is red and tender to touch and it hurts. The patient did not receive any treatment for the adverse events. The outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus; This is a spontaneous report from a contactable consumer (patient). A 70-years-old non pregnant female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 27Jan2021 10:00 (at the age of 70-years-old) (Batch/Lot Number: EL8982) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included blood pressure and Sulfa drugs from an unknown date and unknown if ongoing. Concomitant medication included atorvastatin, atenolol and losartan potassium all drugs were taken for an unspecified indication, start and stop date were not reported. On 29Jan2021, the patient had tinnitus which greatly increased. Original cricket sound went from 2-3 to 9-10. Secondary fan sound went from low hum to giant industrial fan at least 20 after 1st shot. These lasted about 2 weeks and had slightly decreased, especially the fan sound. Annoyance factor can still be around 10. Patient did not receive any treatment for adverse event. The patient had not received any other vaccine within 4 weeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Outcome of the event was not recovered.   Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Blood pressure decreased, Blood pressure measurement, Dizziness, Fall
Clinical narrative: sweats; feels like death is going to take him over; low blood pressure; This is a spontaneous report from a contactable consumer (patient). A 7-decade-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number: not reported) via an unknown route of administration in Mar2021 as dose 1, single for covid-19 immunisation. Medical history included drug hypersensitivity (allergy to strain of mushroom and penicillin in the vaccine in which he is highly allergic). The patient's concomitant medications were not reported. On an unknown date in Mar2021, the patient feels like death is going to take him over and low blood pressure. On an unknown date, the patient had sweats. It was reported that 5 minutes after receiving the vaccine, the patient had low blood pressure and sweats. The patient states today he feels like death is going to take him over. The patient also wants to know if any other person has been affected like this regarding the symptoms he has had. The patient stated it has been 6 months since the first vaccine dose and his doctor told him not to take the second dose, so caller wants to know if anyone has been affected like. It was reported that the patient had previously talked to someone there who told him there is a strain of mushroom and penicillin in the vaccine in which he is highly allergic. The outcome of all the events was reported as unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Feeling abnormal, Feeling cold, Headache, Herpes zoster, Hyperhidrosis
Clinical narrative: sweats; feels like death is going to take him over; low blood pressure; This is a spontaneous report from a contactable consumer (patient). A 7-decade-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number: not reported) via an unknown route of administration in Mar2021 as dose 1, single for covid-19 immunisation. Medical history included drug hypersensitivity (allergy to strain of mushroom and penicillin in the vaccine in which he is highly allergic). The patient's concomitant medications were not reported. On an unknown date in Mar2021, the patient feels like death is going to take him over and low blood pressure. On an unknown date, the patient had sweats. It was reported that 5 minutes after receiving the vaccine, the patient had low blood pressure and sweats. The patient states today he feels like death is going to take him over. The patient also wants to know if any other person has been affected like this regarding the symptoms he has had. The patient stated it has been 6 months since the first vaccine dose and his doctor told him not to take the second dose, so caller wants to know if anyone has been affected like. It was reported that the patient had previously talked to someone there who told him there is a strain of mushroom and penicillin in the vaccine in which he is highly allergic. The outcome of all the events was reported as unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Vomiting
Clinical narrative: sweats; feels like death is going to take him over; low blood pressure; This is a spontaneous report from a contactable consumer (patient). A 7-decade-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number: not reported) via an unknown route of administration in Mar2021 as dose 1, single for covid-19 immunisation. Medical history included drug hypersensitivity (allergy to strain of mushroom and penicillin in the vaccine in which he is highly allergic). The patient's concomitant medications were not reported. On an unknown date in Mar2021, the patient feels like death is going to take him over and low blood pressure. On an unknown date, the patient had sweats. It was reported that 5 minutes after receiving the vaccine, the patient had low blood pressure and sweats. The patient states today he feels like death is going to take him over. The patient also wants to know if any other person has been affected like this regarding the symptoms he has had. The patient stated it has been 6 months since the first vaccine dose and his doctor told him not to take the second dose, so caller wants to know if anyone has been affected like. It was reported that the patient had previously talked to someone there who told him there is a strain of mushroom and penicillin in the vaccine in which he is highly allergic. The outcome of all the events was reported as unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Blood pressure measurement, Cold sweat, Fatigue, Hypotension
Clinical narrative: sweats; feels like death is going to take him over; low blood pressure; This is a spontaneous report from a contactable consumer (patient). A 7-decade-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number: not reported) via an unknown route of administration in Mar2021 as dose 1, single for covid-19 immunisation. Medical history included drug hypersensitivity (allergy to strain of mushroom and penicillin in the vaccine in which he is highly allergic). The patient's concomitant medications were not reported. On an unknown date in Mar2021, the patient feels like death is going to take him over and low blood pressure. On an unknown date, the patient had sweats. It was reported that 5 minutes after receiving the vaccine, the patient had low blood pressure and sweats. The patient states today he feels like death is going to take him over. The patient also wants to know if any other person has been affected like this regarding the symptoms he has had. The patient stated it has been 6 months since the first vaccine dose and his doctor told him not to take the second dose, so caller wants to know if anyone has been affected like. It was reported that the patient had previously talked to someone there who told him there is a strain of mushroom and penicillin in the vaccine in which he is highly allergic. The outcome of all the events was reported as unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Malaise, Salivary hypersecretion
Clinical narrative: sweats; feels like death is going to take him over; low blood pressure; This is a spontaneous report from a contactable consumer (patient). A 7-decade-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number: not reported) via an unknown route of administration in Mar2021 as dose 1, single for covid-19 immunisation. Medical history included drug hypersensitivity (allergy to strain of mushroom and penicillin in the vaccine in which he is highly allergic). The patient's concomitant medications were not reported. On an unknown date in Mar2021, the patient feels like death is going to take him over and low blood pressure. On an unknown date, the patient had sweats. It was reported that 5 minutes after receiving the vaccine, the patient had low blood pressure and sweats. The patient states today he feels like death is going to take him over. The patient also wants to know if any other person has been affected like this regarding the symptoms he has had. The patient stated it has been 6 months since the first vaccine dose and his doctor told him not to take the second dose, so caller wants to know if anyone has been affected like. It was reported that the patient had previously talked to someone there who told him there is a strain of mushroom and penicillin in the vaccine in which he is highly allergic. The outcome of all the events was reported as unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood pressure measurement, Feeling abnormal, Hyperhidrosis, Hypotension
Clinical narrative: sweats; feels like death is going to take him over; low blood pressure; This is a spontaneous report from a contactable consumer (patient). A 7-decade-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number: not reported) via an unknown route of administration in Mar2021 as dose 1, single for covid-19 immunisation. Medical history included drug hypersensitivity (allergy to strain of mushroom and penicillin in the vaccine in which he is highly allergic). The patient's concomitant medications were not reported. On an unknown date in Mar2021, the patient feels like death is going to take him over and low blood pressure. On an unknown date, the patient had sweats. It was reported that 5 minutes after receiving the vaccine, the patient had low blood pressure and sweats. The patient states today he feels like death is going to take him over. The patient also wants to know if any other person has been affected like this regarding the symptoms he has had. The patient stated it has been 6 months since the first vaccine dose and his doctor told him not to take the second dose, so caller wants to know if anyone has been affected like. It was reported that the patient had previously talked to someone there who told him there is a strain of mushroom and penicillin in the vaccine in which he is highly allergic. The outcome of all the events was reported as unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood pressure decreased, Cold sweat, Hypoaesthesia
Clinical narrative: sweats; feels like death is going to take him over; low blood pressure; This is a spontaneous report from a contactable consumer (patient). A 7-decade-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number: not reported) via an unknown route of administration in Mar2021 as dose 1, single for covid-19 immunisation. Medical history included drug hypersensitivity (allergy to strain of mushroom and penicillin in the vaccine in which he is highly allergic). The patient's concomitant medications were not reported. On an unknown date in Mar2021, the patient feels like death is going to take him over and low blood pressure. On an unknown date, the patient had sweats. It was reported that 5 minutes after receiving the vaccine, the patient had low blood pressure and sweats. The patient states today he feels like death is going to take him over. The patient also wants to know if any other person has been affected like this regarding the symptoms he has had. The patient stated it has been 6 months since the first vaccine dose and his doctor told him not to take the second dose, so caller wants to know if anyone has been affected like. It was reported that the patient had previously talked to someone there who told him there is a strain of mushroom and penicillin in the vaccine in which he is highly allergic. The outcome of all the events was reported as unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Dizziness, Ear disorder, Sinus disorder, Temporomandibular joint syndrome
Clinical narrative: dizziness; middle ear infection; acidity reflux; TMJ jaw pains; ear infection and pain; ear infection and pain; facial bone inflamation; lack of sleep; This is a spontaneous report from a contactable consumer. This 39-year-old female consumer (patient) reported that: A 39-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 31Mar2021 at 16:30 (at the age of 39-year-old) as single dose for covid-19 immunisation. Patient was not pregnant at the time of vaccination. The patient medical history was not reported. Patient not diagnosed with covid-19 prior to vaccination. There were no concomitant medications. The patient previously took amoxicillin and experienced drug allergies. Patient was not received any other vaccine four weeks prior vaccination and patient did not receive any medication two weeks prior vaccination. The patient experienced dizziness, middle ear infection, acidity reflux, TMJ jaw pains, ear infection and pain, facial bone inflammation and lack of sleep on 31Mar2021 at 16:30. Since vaccination patient not tested for covid-19. Event resulted to visit doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Therapeutic measures were taken as a result of the events middle ear infection with Antibiotics. The outcome of the events was reported as not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Ear infection, Ear pain, Gastrooesophageal reflux disease, Insomnia
Clinical narrative: dizziness; middle ear infection; acidity reflux; TMJ jaw pains; ear infection and pain; ear infection and pain; facial bone inflamation; lack of sleep; This is a spontaneous report from a contactable consumer. This 39-year-old female consumer (patient) reported that: A 39-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 31Mar2021 at 16:30 (at the age of 39-year-old) as single dose for covid-19 immunisation. Patient was not pregnant at the time of vaccination. The patient medical history was not reported. Patient not diagnosed with covid-19 prior to vaccination. There were no concomitant medications. The patient previously took amoxicillin and experienced drug allergies. Patient was not received any other vaccine four weeks prior vaccination and patient did not receive any medication two weeks prior vaccination. The patient experienced dizziness, middle ear infection, acidity reflux, TMJ jaw pains, ear infection and pain, facial bone inflammation and lack of sleep on 31Mar2021 at 16:30. Since vaccination patient not tested for covid-19. Event resulted to visit doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Therapeutic measures were taken as a result of the events middle ear infection with Antibiotics. The outcome of the events was reported as not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Osteitis, Otitis media, Temporomandibular joint syndrome
Clinical narrative: dizziness; middle ear infection; acidity reflux; TMJ jaw pains; ear infection and pain; ear infection and pain; facial bone inflamation; lack of sleep; This is a spontaneous report from a contactable consumer. This 39-year-old female consumer (patient) reported that: A 39-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 31Mar2021 at 16:30 (at the age of 39-year-old) as single dose for covid-19 immunisation. Patient was not pregnant at the time of vaccination. The patient medical history was not reported. Patient not diagnosed with covid-19 prior to vaccination. There were no concomitant medications. The patient previously took amoxicillin and experienced drug allergies. Patient was not received any other vaccine four weeks prior vaccination and patient did not receive any medication two weeks prior vaccination. The patient experienced dizziness, middle ear infection, acidity reflux, TMJ jaw pains, ear infection and pain, facial bone inflammation and lack of sleep on 31Mar2021 at 16:30. Since vaccination patient not tested for covid-19. Event resulted to visit doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Therapeutic measures were taken as a result of the events middle ear infection with Antibiotics. The outcome of the events was reported as not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Feeling abnormal, Head discomfort, Migraine, Tinnitus
Clinical narrative: On and off headaches; Head pressure (especially while lying in bed); Ears popping; Migraine; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 22Apr2021 at 16:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. On 23Apr2021, the patient experienced on and off headaches, head pressure (especially while lying in bed), ears popping, migraine and brain fog.  Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events on and off headaches, head pressure (especially while lying in bed), ears popping, migraine and brain fog were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vitreous floaters
Clinical narrative: On and off headaches; Head pressure (especially while lying in bed); Ears popping; Migraine; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 22Apr2021 at 16:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. On 23Apr2021, the patient experienced on and off headaches, head pressure (especially while lying in bed), ears popping, migraine and brain fog.  Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events on and off headaches, head pressure (especially while lying in bed), ears popping, migraine and brain fog were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ear discomfort, Feeling abnormal, Head discomfort, Headache, Migraine
Clinical narrative: On and off headaches; Head pressure (especially while lying in bed); Ears popping; Migraine; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 22Apr2021 at 16:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. On 23Apr2021, the patient experienced on and off headaches, head pressure (especially while lying in bed), ears popping, migraine and brain fog.  Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events on and off headaches, head pressure (especially while lying in bed), ears popping, migraine and brain fog were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness
Clinical narrative: Immediate dizziness and pain at injection site. Later that day a high fever of 104 Fahrenheit, body aches, muscle spasms, migraine, blurry vision, tinnitus continued for 24 hours. Ringing in ears has continued sporadically since that date. Dizziness continues sporadically as well.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Immediate post-injection reaction, Injection site pain, Migraine, Muscle spasms
Clinical narrative: Immediate dizziness and pain at injection site. Later that day a high fever of 104 Fahrenheit, body aches, muscle spasms, migraine, blurry vision, tinnitus continued for 24 hours. Ringing in ears has continued sporadically since that date. Dizziness continues sporadically as well.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pyrexia, Tinnitus, Vision blurred
Clinical narrative: Immediate dizziness and pain at injection site. Later that day a high fever of 104 Fahrenheit, body aches, muscle spasms, migraine, blurry vision, tinnitus continued for 24 hours. Ringing in ears has continued sporadically since that date. Dizziness continues sporadically as well.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Blood folate, C-reactive protein normal, Coordination abnormal, Full blood count normal
Clinical narrative: pt felt throat was closing off; feeling in skin that everything was extremely painful (pt was having fever of 101); feeling in skin that everything was extremely painful (pt was having fever of 101); Intense pain in skin lasted a day; mylagia; arthralgia; developed a weak right grip after one week; more generalized weakness overall; This is a spontaneous report from a contactable other hcp. A 41-years-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in Arm Right on 27Mar2021 10:15 (Batch/Lot Number: ER8732) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included migraine, anxiety and borderline glaucoma from an unknown date and unknown if ongoing Preglaucoma. Concomitant medication included clonazepam and escitalopram. The patient previously took penicillin [penicillin nos] and experienced hypersensitivity. The patient did not have COVID prior vaccination. On 27Mar2021 14:15, The patient experienced pt felt throat was closing off, feeling in skin that everything was extremely painful, feeling in skin that everything was extremely painful (pt was having fever of 101), intense pain in skin lasted a day, myalgia, arthralgia, developed a weak right grip after one week, more generalized weakness overall (asthenia). Four hours after first Covid 19 immunization- The patient felt throat was closing off but this resolved without treatment. She also had feeling in skin that everything was extremely painful (patient was having fever of 101). Intense pain in skin lasted a day. Fever, mylagia, arthralgia, and weakness lasted about a week. Patient developed a weak right grip after one week from first COVID shot and had more generalized weakness overall. The patient underwent lab tests and procedures which included blood test: negative on 25May2021 COVID test type post vaccination: Blood test, COVID test name post vaccination: SARS-CoV-2-Ab was unknown, COVID test date: 25May2021, COVID test result: Negative , polymerase chain reaction: negative on 30Mar2021 COVID test post vaccination: COVID test type post vaccination: Nasal Swab, COVID test name post vaccination: PCR at (place withheld), COVID test date: 30Mar2021, COVID test result: Negative, sars-cov-2 antibody test: unknown on 25May2021, sars-cov-2 test: negative on 25May2021. The patient did not received treatment for events. The outcome of events was not resolved.  Follow-up attempts are completed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Grip strength decreased, Hypoaesthesia, Laboratory test normal, Metabolic function test, Myalgia
Clinical narrative: pt felt throat was closing off; feeling in skin that everything was extremely painful (pt was having fever of 101); feeling in skin that everything was extremely painful (pt was having fever of 101); Intense pain in skin lasted a day; mylagia; arthralgia; developed a weak right grip after one week; more generalized weakness overall; This is a spontaneous report from a contactable other hcp. A 41-years-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in Arm Right on 27Mar2021 10:15 (Batch/Lot Number: ER8732) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included migraine, anxiety and borderline glaucoma from an unknown date and unknown if ongoing Preglaucoma. Concomitant medication included clonazepam and escitalopram. The patient previously took penicillin [penicillin nos] and experienced hypersensitivity. The patient did not have COVID prior vaccination. On 27Mar2021 14:15, The patient experienced pt felt throat was closing off, feeling in skin that everything was extremely painful, feeling in skin that everything was extremely painful (pt was having fever of 101), intense pain in skin lasted a day, myalgia, arthralgia, developed a weak right grip after one week, more generalized weakness overall (asthenia). Four hours after first Covid 19 immunization- The patient felt throat was closing off but this resolved without treatment. She also had feeling in skin that everything was extremely painful (patient was having fever of 101). Intense pain in skin lasted a day. Fever, mylagia, arthralgia, and weakness lasted about a week. Patient developed a weak right grip after one week from first COVID shot and had more generalized weakness overall. The patient underwent lab tests and procedures which included blood test: negative on 25May2021 COVID test type post vaccination: Blood test, COVID test name post vaccination: SARS-CoV-2-Ab was unknown, COVID test date: 25May2021, COVID test result: Negative , polymerase chain reaction: negative on 30Mar2021 COVID test post vaccination: COVID test type post vaccination: Nasal Swab, COVID test name post vaccination: PCR at (place withheld), COVID test date: 30Mar2021, COVID test result: Negative, sars-cov-2 antibody test: unknown on 25May2021, sars-cov-2 test: negative on 25May2021. The patient did not received treatment for events. The outcome of events was not resolved.  Follow-up attempts are completed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain of skin, Paraesthesia, Pyrexia, Red blood cell sedimentation rate normal, Rheumatoid factor negative
Clinical narrative: pt felt throat was closing off; feeling in skin that everything was extremely painful (pt was having fever of 101); feeling in skin that everything was extremely painful (pt was having fever of 101); Intense pain in skin lasted a day; mylagia; arthralgia; developed a weak right grip after one week; more generalized weakness overall; This is a spontaneous report from a contactable other hcp. A 41-years-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in Arm Right on 27Mar2021 10:15 (Batch/Lot Number: ER8732) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included migraine, anxiety and borderline glaucoma from an unknown date and unknown if ongoing Preglaucoma. Concomitant medication included clonazepam and escitalopram. The patient previously took penicillin [penicillin nos] and experienced hypersensitivity. The patient did not have COVID prior vaccination. On 27Mar2021 14:15, The patient experienced pt felt throat was closing off, feeling in skin that everything was extremely painful, feeling in skin that everything was extremely painful (pt was having fever of 101), intense pain in skin lasted a day, myalgia, arthralgia, developed a weak right grip after one week, more generalized weakness overall (asthenia). Four hours after first Covid 19 immunization- The patient felt throat was closing off but this resolved without treatment. She also had feeling in skin that everything was extremely painful (patient was having fever of 101). Intense pain in skin lasted a day. Fever, mylagia, arthralgia, and weakness lasted about a week. Patient developed a weak right grip after one week from first COVID shot and had more generalized weakness overall. The patient underwent lab tests and procedures which included blood test: negative on 25May2021 COVID test type post vaccination: Blood test, COVID test name post vaccination: SARS-CoV-2-Ab was unknown, COVID test date: 25May2021, COVID test result: Negative , polymerase chain reaction: negative on 30Mar2021 COVID test post vaccination: COVID test type post vaccination: Nasal Swab, COVID test name post vaccination: PCR at (place withheld), COVID test date: 30Mar2021, COVID test result: Negative, sars-cov-2 antibody test: unknown on 25May2021, sars-cov-2 test: negative on 25May2021. The patient did not received treatment for events. The outcome of events was not resolved.  Follow-up attempts are completed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, Throat tightness, Vitamin B12 normal
Clinical narrative: pt felt throat was closing off; feeling in skin that everything was extremely painful (pt was having fever of 101); feeling in skin that everything was extremely painful (pt was having fever of 101); Intense pain in skin lasted a day; mylagia; arthralgia; developed a weak right grip after one week; more generalized weakness overall; This is a spontaneous report from a contactable other hcp. A 41-years-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in Arm Right on 27Mar2021 10:15 (Batch/Lot Number: ER8732) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included migraine, anxiety and borderline glaucoma from an unknown date and unknown if ongoing Preglaucoma. Concomitant medication included clonazepam and escitalopram. The patient previously took penicillin [penicillin nos] and experienced hypersensitivity. The patient did not have COVID prior vaccination. On 27Mar2021 14:15, The patient experienced pt felt throat was closing off, feeling in skin that everything was extremely painful, feeling in skin that everything was extremely painful (pt was having fever of 101), intense pain in skin lasted a day, myalgia, arthralgia, developed a weak right grip after one week, more generalized weakness overall (asthenia). Four hours after first Covid 19 immunization- The patient felt throat was closing off but this resolved without treatment. She also had feeling in skin that everything was extremely painful (patient was having fever of 101). Intense pain in skin lasted a day. Fever, mylagia, arthralgia, and weakness lasted about a week. Patient developed a weak right grip after one week from first COVID shot and had more generalized weakness overall. The patient underwent lab tests and procedures which included blood test: negative on 25May2021 COVID test type post vaccination: Blood test, COVID test name post vaccination: SARS-CoV-2-Ab was unknown, COVID test date: 25May2021, COVID test result: Negative , polymerase chain reaction: negative on 30Mar2021 COVID test post vaccination: COVID test type post vaccination: Nasal Swab, COVID test name post vaccination: PCR at (place withheld), COVID test date: 30Mar2021, COVID test result: Negative, sars-cov-2 antibody test: unknown on 25May2021, sars-cov-2 test: negative on 25May2021. The patient did not received treatment for events. The outcome of events was not resolved.  Follow-up attempts are completed. No further information is expected.